Harte-Hanks, Inc. (HHS) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.22 --0%
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Harte-Hanks, Inc. (NYSE: HHS) reported Q2 EPS of $0.13, in-line with the analyst estimate of $0.13. Revenue for the quarter came in at $199.1 million versus the consensus estimate of $199.93 million.
For earnings history and earnings-related data on Harte-Hanks, Inc. (HHS) click here.
For earnings history and earnings-related data on Harte-Hanks, Inc. (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
- H.C. Wainwright Reiterates Buy Rating on Ascendis Pharma (ASND)
- JPMorgan upgrades Meta on AI models and agents, sees ’meaningful headroom’
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
